Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Celldex Therapeutics (CLDX) Gross Profit (2024 - 2025)

Celldex Therapeutics (CLDX) has 5 years of Gross Profit data on record, last reported at -$1.1 million in Q4 2025.

  • For Q4 2025, Gross Profit fell 152.16% year-over-year to -$1.1 million; the TTM value through Dec 2025 reached -$4.5 million, down 415.97%, while the annual FY2025 figure was -$4.5 million, 415.97% down from the prior year.
  • Gross Profit reached -$1.1 million in Q4 2025 per CLDX's latest filing, down from -$1.1 million in the prior quarter.
  • Across five years, Gross Profit topped out at $2.1 million in Q3 2024 and bottomed at -$1.5 million in Q1 2025.